董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Itschak Shrem | -- | Chairman of the Board and Director | -- | 未披露 | 未持股 | 2025-09-21 |
| Liat Sidi | -- | Independent Director | -- | 未披露 | 未持股 | 2025-09-21 |
| Moshe Revach | -- | Independent Director | -- | 未披露 | 未持股 | 2025-09-21 |
| Lior Vider | -- | Independent Director | -- | 未披露 | 未持股 | 2025-09-21 |
| Amnon Ben Shay | -- | Independent Director | -- | 未披露 | 未持股 | 2025-09-21 |
| Alon Dayan | -- | Independent Director | -- | 未披露 | 未持股 | 2025-09-21 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Adi Zuloff Shani | 女 | Chief Technology Officer | 57 | 17600.00万 | 未持股 | 2025-09-21 |
| Oz Adler | 男 | Chief Executive Officer and Chief Financial Officer | 38 | 未披露 | 未持股 | 2025-09-21 |
| Amitay Weiss | -- | President | -- | 未披露 | 未持股 | 2025-09-21 |
董事简历
中英对照 | 中文 | 英文- Itschak Shrem
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Liat Sidi
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Moshe Revach
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Lior Vider
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Amnon Ben Shay
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Alon Dayan
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
高管简历
中英对照 | 中文 | 英文- Adi Zuloff Shani
Adi Zuloff Shani自2021年7月14日起担任Clearmind Medicine Inc.首席执行官。Zuloff-Shani博士拥有20多年的研发经验。Zuloff-Shani博士还自2016年2月起担任SciSparc首席技术官。此外，Zuloff-Shani博士自2021年10月起担任Save Foods, Inc.纳斯达克市场代码：SVFD的科学顾问委员会成员，并自2021年11月起担任ORSUS Therapeutics Limited董事会主席。在加入Clearmind Medicine公司之前，2012年至2016年，Zuloff-Shani博士在Macrocure Ltd.（Nasdaq：MCUR）担任开发副总裁，该公司除了领导所有研发活动外，还经常互动，参与所有部门的活动，包括临床、运营、质量保证，质量控制、财务和监管事务。Zuloff-Shani博士拥有以色列Bar-Ilan大学人类生物学和免疫学博士学位。
Adi Zuloff Shani has served as Chief Executive Officer since July 14, 2021. Dr. Zuloff Shani has more than 20 years of experience as a research and development executive. Dr. Zuloff Shani has also served as the Chief Technologies Officer of SciSparc Ltd. since February 2016. In addition, Dr. Zuloff Shani has served as a Member of the Scientific Advisory Board, Save Foods, Inc. (Nasdaq: SVFD) since October 2021, and as Chairman of the board of directors of ORS Therapeutics Limited since November 2021. Prior to joining , and from 2012 to 2016, Dr. Zuloff Shani served as a vice president development at Macrocure Ltd. (Nasdaq: MCUR) where besides leading all research and development activities, she interacted and was involved with the activities of all departments including clinical, operations, quality assurance, quality control, finance, and regulatory affairs. Dr. Zuloff Shani holds a Ph.D. in human biology and immunology from Bar Ilan University, Israel.- Adi Zuloff Shani自2021年7月14日起担任Clearmind Medicine Inc.首席执行官。Zuloff-Shani博士拥有20多年的研发经验。Zuloff-Shani博士还自2016年2月起担任SciSparc首席技术官。此外，Zuloff-Shani博士自2021年10月起担任Save Foods, Inc.纳斯达克市场代码：SVFD的科学顾问委员会成员，并自2021年11月起担任ORSUS Therapeutics Limited董事会主席。在加入Clearmind Medicine公司之前，2012年至2016年，Zuloff-Shani博士在Macrocure Ltd.（Nasdaq：MCUR）担任开发副总裁，该公司除了领导所有研发活动外，还经常互动，参与所有部门的活动，包括临床、运营、质量保证，质量控制、财务和监管事务。Zuloff-Shani博士拥有以色列Bar-Ilan大学人类生物学和免疫学博士学位。
- Adi Zuloff Shani has served as Chief Executive Officer since July 14, 2021. Dr. Zuloff Shani has more than 20 years of experience as a research and development executive. Dr. Zuloff Shani has also served as the Chief Technologies Officer of SciSparc Ltd. since February 2016. In addition, Dr. Zuloff Shani has served as a Member of the Scientific Advisory Board, Save Foods, Inc. (Nasdaq: SVFD) since October 2021, and as Chairman of the board of directors of ORS Therapeutics Limited since November 2021. Prior to joining , and from 2012 to 2016, Dr. Zuloff Shani served as a vice president development at Macrocure Ltd. (Nasdaq: MCUR) where besides leading all research and development activities, she interacted and was involved with the activities of all departments including clinical, operations, quality assurance, quality control, finance, and regulatory affairs. Dr. Zuloff Shani holds a Ph.D. in human biology and immunology from Bar Ilan University, Israel.
- Oz Adler
Oz Adler自2018年4月24日起担任我们的首席财务官，并于2018年3月1日至2018年4月24日担任我们的财务副总裁。他曾担任我们的财务总监（始于2017年9月）。Adler先生拥有广泛的管理，财务，税务和会计经验。Adler自2012年起担任Kost Forer Gabbay&Kasierer（Ernst&Young Global成员）注册会计师。Adler先生拥有以色列管理学院（College of Management，Israel）的会计与商业管理学士学位。
Oz Adler has served as Director since September 2021. Mr. Adler currently serves as the chief executive officer and chief financial officer of SciSparc Ltd. From December 2020 to April 2021, Mr. Adler served as the chief financial officer of Xylo Technologies. Mr. Adler also worked in the audit department of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global beten December 2012 and Augt 2017. Additionally, Mr. Adler currently serves on the board of directors of numero private and publicly traded companies, including Rail Vision Ltd (NASDAQ:RVSN), Clearmind Medicine Inc. (NASDAQ: CMND) (OTC: CMNDF) (FSE:CWY), Chairman of Jeffs' Brands Ltd and vario private companies. Mr. Adler is a certified public accountant in Israel and holds a B.A. degree in Accounting and Biness Management from The College of Management, Israel.- Oz Adler自2018年4月24日起担任我们的首席财务官，并于2018年3月1日至2018年4月24日担任我们的财务副总裁。他曾担任我们的财务总监（始于2017年9月）。Adler先生拥有广泛的管理，财务，税务和会计经验。Adler自2012年起担任Kost Forer Gabbay&Kasierer（Ernst&Young Global成员）注册会计师。Adler先生拥有以色列管理学院（College of Management，Israel）的会计与商业管理学士学位。
- Oz Adler has served as Director since September 2021. Mr. Adler currently serves as the chief executive officer and chief financial officer of SciSparc Ltd. From December 2020 to April 2021, Mr. Adler served as the chief financial officer of Xylo Technologies. Mr. Adler also worked in the audit department of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global beten December 2012 and Augt 2017. Additionally, Mr. Adler currently serves on the board of directors of numero private and publicly traded companies, including Rail Vision Ltd (NASDAQ:RVSN), Clearmind Medicine Inc. (NASDAQ: CMND) (OTC: CMNDF) (FSE:CWY), Chairman of Jeffs' Brands Ltd and vario private companies. Mr. Adler is a certified public accountant in Israel and holds a B.A. degree in Accounting and Biness Management from The College of Management, Israel.
- Amitay Weiss
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介